Zoetis (ZTS) Long-Term Debt Issuances (2013 - 2025)

Zoetis' (ZTS) quarterly Long-Term Debt Issuances came in at $152.0 million in Q4 2025, up 1281.82% on a QoQ basis from $11.0 million in Q4 2018.

Zoetis (ZTS) Long-Term Debt Issuances (2013 - 2025) Analysis & Trends

Zoetis (ZTS) has 3 years of Long-Term Debt Issuances data on file, last reported at $152.0 million in Q4 2025.

On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $152.0 million in Q4 2025; TTM through Dec 2025 was $152.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.0 billion, changed N/A from the prior year.
Long-Term Debt Issuances for Q4 2025 stood at $152.0 million, up from $11.0 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for ZTS reached as high as $152.0 million in Q4 2025 and fell as low as $152.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	3.64 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Vireo Growth	10.57 Bn	10.41 Bn	59.30 Mn	4.50 Mn

Download Data